Franklin Friedman
Vorstandsvorsitzender bei IPFS Corp.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Franklin Friedman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IPFS Corp.
IPFS Corp. Insurance Brokers/ServicesFinance IPFS Corp. engages in the provision of insurance brokerage services. The company was founded by Tom Charbonneau in 1977 and is headquartered in Kansas City, MO. | Vorstandsvorsitzender | 01.01.2019 | - |
Präsident | 01.01.2019 | - | |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | 01.11.2019 | - |
Karriereverlauf von Franklin Friedman
Ehemalige bekannte Positionen von Franklin Friedman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DECIPHERA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.11.2019 | 11.06.2024 |
Independent Dir/Board Member | 01.11.2019 | 11.06.2024 | |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Vorstandsvorsitzender | 01.01.2014 | 01.01.2015 |
Geschäftsführer | 01.06.2015 | 01.11.2019 | |
Finanzdirektor/CFO | 01.06.2011 | 01.05.2016 | |
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY. | Vorstandsvorsitzender | 01.01.2014 | 01.01.2015 |
Geschäftsführer | 01.06.2015 | 01.11.2019 | |
Finanzdirektor/CFO | 01.06.2011 | 01.01.2015 |
Ausbildung von Franklin Friedman
University of Kansas | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Chief Executive Officer | 3 |
Chief Operating Officer | 2 |
Director of Finance/CFO | 2 |
Sektoral
Commercial Services | 3 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
IPFS Corp.
IPFS Corp. Insurance Brokers/ServicesFinance IPFS Corp. engages in the provision of insurance brokerage services. The company was founded by Tom Charbonneau in 1977 and is headquartered in Kansas City, MO. | Finance |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY. | Commercial Services |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. The company was founded by Peter A. Petillo and Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Franklin Friedman
- Erfahrung